Wendell David Associates Inc. trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 65,938 shares of the pharmacy operator’s stock after selling 3,925 shares during the period. Wendell David Associates Inc.’s holdings in Walgreens Boots Alliance were worth $4,807,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of WBA. BlueMountain Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth $103,000. CSat Investment Advisory L.P. purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth $104,000. Squar Milner Financial Services LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth $106,000. Kaizen Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares during the last quarter. Finally, Camarda Financial Advisors LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth $137,000. Institutional investors and hedge funds own 61.92% of the company’s stock.

Shares of Walgreens Boots Alliance stock opened at $73.50 on Friday. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $80.68. The firm has a market capitalization of $72.35 billion, a P/E ratio of 14.41, a P/E/G ratio of 1.11 and a beta of 1.04. The company has a current ratio of 0.93, a quick ratio of 0.47 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. As a group, analysts forecast that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.

WBA has been the topic of a number of research reports. Loop Capital raised their price target on Walgreens Boots Alliance to $80.00 and gave the stock a “buy” rating in a research note on Friday, June 29th. Pivotal Research dropped their price target on Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating on the stock in a research note on Monday, July 2nd. Mizuho downgraded Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $64.00 price target on the stock. in a research note on Monday, July 2nd. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 16th. Finally, TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $76.94.

In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 1,697,438 shares of the firm’s stock in a transaction on Monday, July 16th. The shares were acquired at an average cost of $63.92 per share, with a total value of $108,500,236.96. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the sale, the director now directly owns 10,943 shares in the company, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: Intrinsic Value

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.